Feedback / Questions
live-attenuated Bordetella pertussis vaccine (BPZE1) - ILiAD Biotechnologies
https://www.businesswire.com/news/home/20250127208008/en/ILiAD-and-hVIVO-Sign-LOI-for-Pivotal-Phase-3-Trial-of-BPZE1-Pertussis-Vaccine-Following-FDA-Meeting
Jan 27, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next